NO950723L - Optisk aktivt hydrokinin-1-(3-aminofenyl)etansulfonat, dets fremstilling og anvendelse - Google Patents

Optisk aktivt hydrokinin-1-(3-aminofenyl)etansulfonat, dets fremstilling og anvendelse

Info

Publication number
NO950723L
NO950723L NO950723A NO950723A NO950723L NO 950723 L NO950723 L NO 950723L NO 950723 A NO950723 A NO 950723A NO 950723 A NO950723 A NO 950723A NO 950723 L NO950723 L NO 950723L
Authority
NO
Norway
Prior art keywords
preparation
ethanesulfonate
optically active
pct
hydroquinin
Prior art date
Application number
NO950723A
Other languages
English (en)
Norwegian (no)
Other versions
NO950723D0 (no
Inventor
Claude Guyon
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO950723D0 publication Critical patent/NO950723D0/no
Publication of NO950723L publication Critical patent/NO950723L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/02Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/24Sulfonic acids having sulfo groups bound to acyclic carbon atoms of a carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C07D453/04Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO950723A 1992-09-11 1995-02-24 Optisk aktivt hydrokinin-1-(3-aminofenyl)etansulfonat, dets fremstilling og anvendelse NO950723L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9210839A FR2695641B1 (fr) 1992-09-11 1992-09-11 (Amino-3 phényl)-1 éthanesulfonate d'hydroquinine optiquement actif, sa préparation et son utilisation.
PCT/FR1993/000848 WO1994006792A1 (fr) 1992-09-11 1993-09-06 (amino-3 phenyl)-1 ethanesulfonate d'hydroquinine optiquement actif, sa preparation et son utilisation

Publications (2)

Publication Number Publication Date
NO950723D0 NO950723D0 (no) 1995-02-24
NO950723L true NO950723L (no) 1995-02-24

Family

ID=9433404

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950723A NO950723L (no) 1992-09-11 1995-02-24 Optisk aktivt hydrokinin-1-(3-aminofenyl)etansulfonat, dets fremstilling og anvendelse

Country Status (19)

Country Link
US (1) US5625066A (ja)
EP (1) EP0659184B1 (ja)
JP (1) JPH08503929A (ja)
KR (1) KR950703560A (ja)
AT (1) ATE134632T1 (ja)
AU (1) AU678388B2 (ja)
CA (1) CA2144158A1 (ja)
DE (1) DE69301662T2 (ja)
DK (1) DK0659184T3 (ja)
ES (1) ES2083874T3 (ja)
FR (1) FR2695641B1 (ja)
GR (1) GR3019144T3 (ja)
HU (1) HUT73492A (ja)
IL (1) IL106965A (ja)
NO (1) NO950723L (ja)
NZ (1) NZ255451A (ja)
RU (1) RU95108885A (ja)
WO (1) WO1994006792A1 (ja)
ZA (1) ZA936605B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2695643B1 (fr) * 1992-09-11 1994-11-25 Rhone Poulenc Rorer Sa Dérivés d'uréido-acétamide, leur préparation et les médicaments les contenant.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093498A (en) * 1983-04-01 1992-03-03 Merck & Co., Inc. Trifluoromethylbenzyl containing quaternary salts
WO1990005525A1 (en) * 1988-11-23 1990-05-31 Pfizer Inc. Quinuclidine derivatives as substance p antagonists
US5382590A (en) * 1990-02-09 1995-01-17 Rhone-Poulenc Rorer S.A. N-phenyl-N-acetamidoglycinamides, their preparation and medicaments containing them
FR2667864B2 (fr) * 1990-03-07 1994-08-05 Rhone Poulenc Sante Derives de n-phenyl glycinamides, leur preparation et les medicaments les contenant.
EP0518961A1 (fr) * 1990-03-07 1992-12-23 Aventis Pharma S.A. Derives de glycinamide, leur preparation et les medicaments les contenant
FR2678938B1 (fr) * 1991-07-10 1993-10-08 Rhone Poulenc Rorer Sa Derives de pyrrolidine, leur preparation et les medicaments les contenant.
FR2682381B1 (fr) * 1991-10-10 1995-04-07 Rhone Poulenc Rorer Sa Derives de benzodiazepine, leur preparation et les medicaments les contenant.

Also Published As

Publication number Publication date
DE69301662T2 (de) 1996-09-05
NO950723D0 (no) 1995-02-24
ZA936605B (en) 1994-03-29
EP0659184B1 (fr) 1996-02-28
HU9500709D0 (en) 1995-04-28
DE69301662D1 (de) 1996-04-04
DK0659184T3 (da) 1996-03-18
RU95108885A (ru) 1997-01-10
WO1994006792A1 (fr) 1994-03-31
EP0659184A1 (fr) 1995-06-28
GR3019144T3 (en) 1996-05-31
NZ255451A (en) 1996-11-26
CA2144158A1 (fr) 1994-03-31
FR2695641A1 (fr) 1994-03-18
ATE134632T1 (de) 1996-03-15
US5625066A (en) 1997-04-29
HUT73492A (en) 1996-08-28
IL106965A0 (en) 1993-12-28
ES2083874T3 (es) 1996-04-16
FR2695641B1 (fr) 1994-11-25
AU678388B2 (en) 1997-05-29
AU4965693A (en) 1994-04-12
KR950703560A (ko) 1995-09-20
IL106965A (en) 1997-04-15
JPH08503929A (ja) 1996-04-30

Similar Documents

Publication Publication Date Title
DE69326250D1 (de) Neuropeptide y antagoniste
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DE69327536D1 (de) Fibrinogenrezeptor-antagonisten
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
ATE200895T1 (de) Betain-geminitenside auf der basis von aminen
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
HUT73165A (en) Herbicidal heterocyclic-substituted pyridines
TW261532B (ja)
NO950723D0 (no) Optisk aktivt hydrokinin-1-(3-aminofenyl)etansulfonat, dets fremstilling og anvendelse
ATE183100T1 (de) Neuartige glukohydrolase-inhibitoren nützlich als antidiabetische, antivirale und antimetastatische mittel
IL106964A0 (en) Optically active alkylammonium 1-(3-aminophenyl)-ethanesulphonate derivatives,their preparation and their use
FI953568A0 (fi) Kytkimen suojausjärjestely
SE9301831D0 (sv) Pharmaceutical compositions
ZA939227B (en) Novel triazoloquinazolines,their preparation and use